Ping-Chung Leung

TL;DR: A once-yearly infusion of zoledronic acid during a 3-year period significantly reduced the risk of vertebral, hip, and other fractures and was associated with a significant improvement in bone mineral density and bone metabolism markers.

TL;DR: Small differences in bone density and markers in those who continued versus those who stopped treatment suggest residual effects, and therefore, after 3 years of annual ZOL, many patients may discontinue therapy up to 3 years, however, vertebral fracture reductions suggest that those at high fracture risk, particularly vertebral fractures, may benefit by continued treatment.

TL;DR: Subjects with osteoporosis have decreased vertebral marrow perfusion and increased marrow fat compared with these parameters in subjects with osteopenia and subjects with normal bone density.

TL;DR: The modified Pfirrmann grading system is useful at discriminating severity of disc degeneration in elderly subjects and can be applied with good intra- and interobserver agreement.

TL;DR: The present study aimed to explore the SARS-preventing mechanisms of HC in the immunological and anti-viral aspects and provided scientific data to support the efficient and safe use of HC to combat SARS.